The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

The Company claims the sponge powder exfoliates the skin, promotes collagen production, and opens closed comedones.

Vitamin A is fat-soluble and can build up in the body. This can lead to dry skin, blurry vision, bone problems and liver damage. In pregnant women, it can even cause birth defects. Dr Lesley Motheral, ...

Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts.

Licensing criteria should be equitable, nondiscriminatory, objective, and compatible with similar risks in other populations.

HealthDay News — With a new law, signed by Gov. Spencer Cox on March 27, Utah has become the first US state to ban the addition of fluoride to public drinking water, The New York Times reported. The ...

HealthDay News — Combination lipid-lowering therapy (LLT) is associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C) compared with statin monotherapy, according to a study ...

Fitusiran is a small interference RNA therapeutic designed to prevent bleeds in patients with hemophilia A or B by lowering antithrombin.

The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.

The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

The Food and Drug Administration (FDA) has expanded the approval of Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) to include patients with ...